» Articles » PMID: 38045022

The Depiction of Hypertension in Heart Imaging Examinations: An Up-to-Date Review of the Evidence

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension is one of the main preventable cardiovascular (CV) risk factors all over the years, closely related to CV morbidity and mortality. One of the most common hypertensive target organ damages is hypertensive heart disease (HHD), including left ventricular hypertrophy, which progresses gradually and leads to systolic or diastolic dysfunction of the left ventricular, and finally to end-stage heart failure. Regarding its prevalence and the need for early diagnosis, assessment of heart imaging examination is of major importance. Echocardiography has been used as the standard imaging technique to evaluate HHD for years, providing an accurate evaluation of the left ventricular geometry, along with the systolic and diastolic function. However, nowadays there is a growing interest in cardiovascular magnetic resonance (CMR). Despite the importance of the use of echocardiography in everyday clinical practice, numerous studies have shown the superiority of CMR as an imaging technique for clinical and research purposes, mainly due to its strength to provide an unlimited area of view, as well as the identification and quantification of the type and extent of myocardial fibrosis. Hence, this review aims to analyze the importance of heart imaging in the hypertensive population, with a special interest in CMR imaging.

Citing Articles

A study on the application of radiomics based on cardiac MR non-enhanced cine sequence in the early diagnosis of hypertensive heart disease.

Ma Z, Wang S, Xue L, Zhang X, Zheng W, Zhao Y BMC Med Imaging. 2024; 24(1):124.

PMID: 38802736 PMC: 11129462. DOI: 10.1186/s12880-024-01301-9.

References
1.
Ciulla M, Paliotti R, Hess D, Tjahja E, Campbell S, Magrini F . Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization. J Am Soc Echocardiogr. 1997; 10(6):657-64. DOI: 10.1016/s0894-7317(97)70028-2. View

2.
Levy D, Garrison R, Savage D, Kannel W, CASTELLI W . Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322(22):1561-6. DOI: 10.1056/NEJM199005313222203. View

3.
AlFakih K, Walters K, Jones T, Ridgway J, Hall A, Sivananthan M . New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension. 2004; 44(2):175-9. DOI: 10.1161/01.HYP.0000135249.66192.30. View

4.
Redfield M, Jacobsen S, Burnett Jr J, Mahoney D, Bailey K, Rodeheffer R . Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289(2):194-202. DOI: 10.1001/jama.289.2.194. View

5.
Bottini P, CARR A, Prisant L, Flickinger F, Allison J, Gottdiener J . Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens. 1995; 8(3):221-8. DOI: 10.1016/0895-7061(94)00178-E. View